First patient enrolled in the Phase 3 trial a few days ago in the US....obviously this news helped elevate the company onto serious money's radar screens....compared to other global pharmaceutical stocks still value, especially with yet another blockbuster on the horizon.
First patient enrolled in the Phase 3 trial a few days ago in...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$299.31 |
Change
3.530(1.19%) |
Mkt cap ! $144.9B | |||
| Open | High | Low | Value | Volume |
| $296.29 | $299.39 | $296.14 | $121.1M | 405.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29 | $299.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $299.34 | 41 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |